baber/WOPTO huggingface dataset:
Patent JP-2509201-B2 (JP)
IPC: G01N33/569
Filed: 1986-12-23
Granted: 1996-06-19
Abstract: A method of qualitatively or quantitatively determining a component of a complex formed between at least one specific binding agent and its corresponding bindable substance. Said method comprises labelling at least one component of said complex with a marker which is easier to determine than the complex itself, whereby the marker used consists of latex particles which can be detected visually either by colour or fluorescence. Preferably the marker consists of coloured or colourable latex particles and the determination is based on the colour characteristics of the latex particles as such or, in the instance that colourable latex particles are used, on the colour characteristics of the coloured particles derived therefrom. The colour, respectively fluorescence signal is, if necessary after development, easily detected and optionally quantified. The invention further comprises coloured or colourable latex particles coated with specific binding proteins and test kits containing the same.
Patent JP-3984380-B2 (JP)
IPC: E05F3/20
Filed: 1998-11-02
Granted: 2007-10-03
Abstract: PROBLEM TO BE SOLVED: To provide an automatic door-closing hinge with a cushioning mechanism, which has a simple structure and is manufactured easily and in which there is no possibility of the generation of oil spill or the like, in a hinge used for an open-close door such as an entrance door, particularly the automatic door-closing hinge with the cushioning mechanism having a function, in which door-closing operation is conducted automatically while a shock at the time of door closing is relaxed. SOLUTION: A cylindrical cylinder 3 is installed integrally on one of a pair of slats 1, 2 constituting the hinge, a piston 7 forward moved and retreated while being interlocked with the rotary operation of the other slat 1 is mounted into the cylinder 3 while a compression coil spring 19 shrunk by the forward operation of the piston 7 at the time of door opening is housed and arranged into the cylinder 3. The other slat 1 is turned in the door-closing direction as being interlocked with the return operation of the piston 7 by the restoring force of the compression coil spring 19 while a shock at the time of door closing is relaxed by air cushion working in the cylinder 3 by the return operation of the piston 7 at that time.
Patent JP-3375842-B2 (JP)
IPC: A61L27/16
Filed: 1996-12-03
Granted: 2003-02-10
Abstract: Novel polymerizable yellow dyes are disclosed. Additionally, novel and known dyes are used to block or lower the intensity of blue light transmitted through ocular lenses and other windows.
Patent JP-3828593-B2 (JP)
IPC: A61K38/08
Filed: 1994-12-28
Granted: 2006-10-04
Abstract: Bradykinin antagonists and the physiologically tolerated salts thereof are suitable for the treatment or prophylaxis of viral diseases.
Patent JP-3553669-B2 (JP)
IPC: A61K9/127
Filed: 1994-12-28
Granted: 2004-08-11
Abstract: Industrial prodn. of a compsn. (A), contg. reconstituted lipoprotein particles (LPP), comprises first mixing an aq. apolipoprotein (APL) soln. of protein content 1-40 g/l with an aq. lipid(L)-detergent (D) soln., at mole ratio L:D 1:0.5-4 and wt. ratio APL:L 1:1.5-5.The resulting mixt. was incubated at a temp. within 10 degrees C of the phase transition temp. of L in water, then the detergent removed (by exclusion according to mol. size or by using an adsorbent) so that LPP of dia. 5-50 nm and mol.wt. 0.05-1 MD are formed. Without further purificn. steps, over 95% of added protein and over 90% of total L is bound in LPP.Opt. the resulting liq. prod. is lyophilised in presence of a carbohydrate stabiliser.(A) contains 18-22 g/l protein and, at 18-22 degrees C, has turbidity below 40 NTV.
Patent JP-2956029-B2 (JP)
IPC: A61K9/06
Filed: 1997-12-26
Granted: 1999-10-04
Abstract: A medicine for nasal administration or for administration to the eye contains azelastine as active ingredient, it also being possible for the azelastine to be in the form of a physiologically tolerated salt.
Patent JP-3327552-B2 (JP)
IPC: F01N13/02
Filed: 1993-05-24
Granted: 2002-09-24
Abstract: PCT No. PCT/FI93/00217 Sec. 371 Date Jan. 31, 1995 Sec. 102(e) Date Jan. 31, 1995 PCT Filed May 24, 1993 PCT Pub. No. WO93/24745 PCT Pub. Date Dec. 9, 1993The invention relates to a catalytic combustion engine exhaust gas purifier with additional air supply. The exhaust gas purifier comprises a housing structure (1) accommodating an exhaust gas inlet (2), at least one catalyst element (3), means (4) for laminarizing the exhaust gas flow, means (5 and 6) for dividing the housing structure (1) into several chambers (7-9), an exhaust gas outlet (10) and, additionally, means (11) for supplying additional air (17 and 18) into the exhaust gas flow (14 and 15) in the housing structure (1). One or more suction plates (19 and 20) are provided in the chamber (8) after the means (4) laminarizing the exhaust gas flow and at the same time in the vicinity of the means (11) supplying additional air. The suction plates (19 and 20) comprise exhaust gas ports and additional air (17 and 18) ports, and the suction plates (19 and 20) are arranged against the exhaust gas flow (14 and 15) and the additional air flow (17 and 18) so that the additional air is arranged to be sucked through the additional air ports and from the suction plates (19 and 20) into the exhaust gas flow (15) passing through the exhaust gas ports of the suction plates (19 and 20).
Patent JP-3459417-B2 (JP)
IPC: G06F3/05
Filed: 1992-05-28
Granted: 2003-10-20
Abstract: A method for converting and encoding an analog signal to a digital format and subsequently decoding and converting said digital format to recover the analog signal, comprising the steps of monitoring the physical characteristics of an analog waveform to be converted to a digital format, converting said analog waveform to said digital format, encoding within said digital formal control information indicative of the physical characteristics of said analog waveform, whereby said analog waveform can subsequently be more accurately reconstructed from said digital format, decoding from said digital format said control information indicative of certain specified physical characteristics of said analog waveform, converting said digital format signal to said analog waveform, and peak limiting and restoring, and introducing compatible signal reconstruction compensation, in accordance with said control information during said converting process, said information facilitating subsequent more accurate reconstruction of said analog waveform from said digital format.
Patent JP-3215840-B2 (JP)
IPC: G01S17/89
Filed: 1992-07-07
Granted: 2001-10-09
Abstract: A digital filter system for filtering an input signal having a plurality of differing input frequencies, comprises filter means for providing at least one filter singularity frequency, frequency shift means for receiving said plurality of differing input frequencies and applying a frequency shift to the differing input frequencies of said plurality of differing input frequencies to provide frequency shifted signals, and means for applying said frequency shifted signals to said filter means to filter said frequency shifted signals. A method for digital filtering of an input signal having a plurality of differing input frequencies, comprises the steps of providing filter means having a filter singularity point, receiving said plurality of differing input frequencies and applying frequency shift means to the differing input frequencies of said plurality of differing input frequencies of said plurality of differing input frequencies to provide frequency shifted signals, and applying said frequency shifted signals to said filter means to filter said frequency shifted signals.
Patent JP-3505177-B2 (JP)
IPC: A61M1/00
Filed: 1993-07-14
Granted: 2004-03-08
Abstract: This invention pertains to the use of a degassed perfluorocarbon ("PFC") liquid as a method of removing gas emboli from parts of a patient's internal anatomy. Moreover, the invention can be used as a method of imaging parts of a patient's internal anatomy. Furthermore, the invention can also be used as a way of delivering biological agents to parts of a patient's internal anatomy which contain or are surrounded by gas emboli and/or which are to be imaged. In this invention, a degassed PFC liquid is delivered to a region within the patient's internal anatomy which contains gas emboli and/or which is to be imaged. If gas emboli are present, the degassed liquid is permitted to absorb at least a portion of the emboli. Thereafter, the emboli-containing liquid is removed from the patient or is used as an imaging agent. If gas emboli are not present, the cite is imaged before the degassed liquid reaches atmospheric equilibrium. Thereafter, the liquid is removed from the patient. Moreover, by mixing a biological agent with the degassed PFC liquid, the mixture can be used as a way of topically treating parts within a patient's internal anatomy. Furthermore, by regulating the temperature of the degassed liquid, it can also be used as a way of hypo- or hyperthermically treating the patient.
Patent JP-3074022-B2 (JP)
IPC: B66C23/42
Filed: 1993-07-08
Granted: 2000-08-07
Abstract: An outer-boom crane comprising a first boom section (1) and an outer boom (2) which is pivotable relative to the first boom section by means of a hydraulic cylinder (12) whose one end is connected to the first boom section by a first articulation (13) and whose opposite end is connected to the outer boom (2) by a second articulation (14). Between the two booms (1, 2), there is provided at least one link device (15) which is connected to the first boom section by a third articulation (16) and to the outer boom (2) by a fourth articulation (17) which is spaced from the second articulation (14) and from the third articulation (16), more specifically with the third articulation (16) located at a greater distance from the fourth articulation (17) than the second articulation (14). By means of the link device (15), the outer boom (2) can switch articulation points so as to pivot, within its working range, about a fourth articulation (17) which is situated at a great distance from the main articulation (3) of the first boom section while, when pivoting towards and away from its parking position on the upper side of the first boom section, it is pivoted about the third articulation (16) which is situated considerably closer to the main articulation (3).
Patent JP-3513518-B2 (JP)
IPC: C08F210/06
Filed: 1993-09-08
Granted: 2004-03-31
Abstract: A process for the production of propylene/1-butene copolymers comprising: reacting propylene and 1-butene monomers in the presence of a catalyst system comprising: (a) a solid supported catalyst component is prepared by the method comprising: (i) co-comminuting magnesium halide support base and aluminum trihalide in a molar ratio from about 8:0.5 to about 8:3 in the absence of added electron donor; and (ii) then co-comminuting the product of step (i) in the absence of added electron donor with sufficient titanium tetrahalide to provide a molar ratio of magnesium halide to titanium tetrahalide from about 8:0.1 to about 8:1.0. (b) a trialkylaluminum co-catalyst, having from 1 to 9 carbon atoms in each alkyl group in an amount such that the Al/Ti ratio is between about 50:1 and about 500:1. (c) an alkoxy silane component of the formula RnSi(OR')4-n where n=1-3, R=aryl or alkyl and R'=C1-3 alkyl in a sufficient quantity such that the molar ratio of organoaluminum co-catalyst to alkoxy silane is in the range from about 20:1 to about 45:1. said copolymer being characterized by a propylene content of 25 to 50 wt%, a 1-butene content of 75 to 50 wt% and a tensile strength of at least 300 psig.
Patent JP-H0444109-B2 (JP)
IPC: F03B15/20
Filed: 1988-11-11
Abstract: PCT No. PCT/CH88/00209 Sec. 371 Date Jul. 13, 1989 Sec. 102(e) Date Jul. 13, 1989 PCT Filed Nov. 11, 1989 PCT Pub. No. WO89/05402 PCT Pub. Date Jun. 15, 1989.The turbine (1) has a control and regulating system with a pump (31), the pressure of which changes proportionally to the second power of the flow delivered by the pump or to the second power of the speed (n2) of the turbine (1). The hydraulic follow-up piston arrangement with the pilot piston (41) and the control piston (5) for regulating the speed of the turbine, is fed by this only pump (31), which permits a particularly compact and space-saving construction. The turbine can be used as a motor or drive in applications other than the generating of electricity, such as, for example, for rope winches.
Patent JP-3160909-B2 (JP)
IPC: A61K31/435
Filed: 1994-09-06
Granted: 2001-04-25
Abstract: PCT No. PCT/JP94/01465 Sec. 371 Date May 6, 1996 Sec. 102(e) Date May 6, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/07279 PCT Pub. Date Mar. 16, 1995A new process for preparing a compound of the formula:   <IMAGE>
Patent JP-3854629-B2 (JP)
IPC: G11C16/04
Filed: 1992-03-13
Granted: 2006-12-06
Abstract: A single transistor electrically programmable and erasable memory cell (10) is disclosed. The single transistor has a source (14), a drain (16) with a channel region (18) therebetween, defined on a substrate. A first insulating layer (20) is over the source, channel and drain regions. A floating gate (22) is positioned on top of the first insulating layer over a portion of the channel region and over a portion of the source region. A second insulating layer (25) has a top wall which is over the floating gate, and a sidewall which is adjacent thereto. A control gate has a first portion (24) which is over the first insulating layer and immediately adjacent to the sidewall of the second insulating layer. The control gate has a second portion (26) which is over the top wall of the second insulating layer and is over the floating gate. Erasure of the cell is accomplished by the mechanism of Fowler-Nordheim tunneling from the floating gate through the second insulating layer to the control gate.
Patent JP-2892158-B2 (JP)
IPC: H04N7/173
Filed: 1994-09-28
Granted: 1999-05-17
Abstract: A digital video recording and playback system, and a method for recording video program information on a multiple-channel recording medium, such as tape. The system includes multiple playback devices, such as VCR decks. Each playback device outputs video program data from each of multiple channels of the recording medium at the same time. Synchronizing circuitry controls the playback devices so that alternately one is in playback mode while the other is in non-playback mode. The sequential outputs of the two playback devices can create a continuous and complete video program. One playback device is in playback mode while the other is rewinding. Because the video program data is recorded on the multiple channels with staggered starting times, little wait time occurs between the request for a program by a viewer and the start time of the program.
Patent JP-3480499-B2 (JP)
IPC: C04B35/565
Filed: 1992-12-11
Granted: 2003-12-22
Abstract: PCT No. PCT/AU92/00661 Sec. 371 Date Aug. 3, 1994 Sec. 102(e) Date Aug. 3, 1994 PCT Filed Dec. 11, 1992 PCT Pub. No. WO93/12051 PCT Pub. Date Jun. 24, 1993A process for the production of dense polycrystalline silicon carbide shaped articles; includes (a) heating a powder compact containing silicon carbide and alumina or a precursor thereof to an intermediate temperature, and maintaining the said intermediate temperature for an extended dwell, and then (b) heating the product of step (a) to a higher temperature for sufficient time to produce a dense polycrystalline silicon carbide product.
Patent JP-3456653-B2 (JP)
IPC: A23L2/44
Filed: 1995-09-13
Granted: 2003-10-14
Abstract: PCT No. PCT/EP95/03599 Sec. 371 Date Mar. 19, 1997 Sec. 102(e) Date Mar. 19, 1997 PCT Filed Sep. 13, 1995 PCT Pub. No. WO96/09774 PCT Pub. Date Apr. 4, 1996A drink preservative for sterilizing drinks containing: a) K-sorbate and/or Na-benzoate; b) ascorbic acid; and c) dimethyl dicarbonate; a method for sterilizing and preserving drinks by incorporating the drink preservative into drinks; and drinks preserved with the drink preservative.
Patent JP-3115594-B2 (JP)
IPC: C08G18/08
Filed: 1991-07-10
Granted: 2000-12-11
Abstract: PCT No. PCT/EP91/01284 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Jul. 10, 1991 PCT Pub. No. WO92/01725 PCT Pub. Date Feb. 6, 1992.Thixotropic polyurethane systems based on a polyol component and an isocyanate component, the polyol component containing a mixture of polyamidoamine and low molecular weight, polyfunctional amines, more particularly aromatic amines, which are suitable in particular as adhesive systems for special applications.
Patent JP-2948906-B2 (JP)
IPC: A61K9/00
Filed: 1991-07-08
Granted: 1999-09-13
Abstract: An osmotic device (10) is disclosed that comprises a first and second means that act together to provide a drug-free interval prior to the delivery of a drug (15) from inside the device (10). The first means slows the passage of fluid through wall (12) into device (10), and the second means in the device delays the delivery of drug (16) from device (10).
Patent JP-3556224-B2 (JP)
IPC: C09J153/00
Filed: 1994-10-31
Granted: 2004-08-18
Abstract: The present invention encompasses nontapered block copolymers of the following structure and adhesives containing themD-A-(B-A)n-Dxor(D-A-B)z-Ywhere A is a vinyl aromatic hydrocarbon polymer block, B and D are hydrogenated conjugated diene polymer blocks wherein if the diene is butadiene, it must have a vinyl content of at least 30 percent by weight, n is an integer from 1 to 5, x is 0 or 1, z is an integer from 2 to 30, and Y is a multifunctional coupling agent and the copolymer has a vinyl aromatic hydrocarbon content of from 9 to 35 percent by weight. The ratio of the molecular weight of D to that of B ranges in accordance with the normalized molecular weight factor which may range from greater than 0 up to 180x10-6.
Patent JP-3926840-B2 (JP)
IPC: A61K48/00
Filed: 1995-10-17
Granted: 2007-06-06
Abstract: Disclosed is a method of down-regulating the expression of a gene in an animal, wherein a pharmalogical formulation comprising an oligonucleotide complementary to the gene is orally administered to an animal. The oligonucleotide administered has non-phosphodiester internucleotide linkages and includes at least one 2'-substituted ribonucleotide, the oligonucleotide inhibiting the expression of a product of the gene, thereby down-regulating the expression of the gene.
Patent JP-4112616-B2 (JP)
IPC: C12N5/08
Filed: 1996-10-04
Granted: 2008-07-02
Abstract: A bio-artificial organ system is provided comprising a wall surrounding a space which has a solid support for cell cultivation. The space includes a there dimensional matrix in the form of a highly porous sheet or mat and including a physiologically acceptable network of fibers or an open-pore foam structure; hydrophobic hollow fibers permeable to gaseous oxygen or gaseous carbon dioxide evenly distributed through the three dimensional matrix material and arranged in parallel running from one end of the matrix material to the other end of the matrix material. Cells obtained from organs are present in the extra fiber space for culture wherein the cells are provided with sufficient oxygenation and are maintained as small aggregates with three dimensional attachment.
Patent JP-3595841-B2 (JP)
IPC: C12Q1/68
Filed: 1993-12-03
Granted: 2004-12-02
Abstract: A system is described for the use of a ribozyme as a diagnostic tool for detecting the presence of a nucleic acid, protein, or other molecule, in which the formation of an active ribozyme and cleavage of an assayable marker is dependent on the presence or absence of the specific target molecule. The essential component is a ribozyme specifically but reversibly binding a selected target in combination with a labelled co-target, preferably immobilized on a support structure. When both the target and co-target are bound, the ribozyme cleaves the label from the co-target, which is then quantifiable. Since the ribozyme is reversibly bound by target and co-target, it can reassociate with additional co-target, cleaving more label, thereby amplifying the reaction signal. In one embodiment, the target is a nucleic acid hybridizing to complementary sequences that form part of the ribozyme; in a second embodiment, the target is a protein or other macromolecule which is bound by interactions with a portion of the ribozyme molecule. In another embodiment, a thermostable ribozyme is used, so that improperly bound ribozyme is destabilized and inactive at elevated temperatures. A method for isolating regulatable ribozymes is also disclosed. The regulatable ribozymes are useful in the method for detecting the presence of a specific macromolecule, or can be used in in vitro or in vivo methods for inactivation or activation of the cleavage of target RNA molecules. <IMAGE>   <IMAGE>   <IMAGE>
Patent JP-4104171-B2 (JP)
IPC: H04L9/32
Filed: 1997-09-25
Granted: 2008-06-18
Abstract: The invention concerns a method and a system enabling a telecommunication operator (12) to identify rapidly and to debit in complete security the accounts of subscribers of a telephone network. The method comprises the following steps: the telecommunication operator (12) provides each of its subscribers (11) with a subscriber card (10), formatted like a credit card, personalised by specific identifiers for each subscriber and for each subscriber card; said card (10), formatted like a credit card, personalised by specific identifiers for each subscriber and for each subscriber card; said card (10), formatted like a credit card, emits brief identifying sound signals, of the DTMF type, at least partly encrypted, varying with each operation, when it is actuated (14) by the customer (11); the sound signals are received by the microphone (17) of the handset (16) and are converted into electric signals, before being transmitted by the communication network (15) to the computer service (18) of the telecommunication operator (12); the transmitted signals are electronically processed and decrypted (24) by the computer service (18) of the telecommunication operator (12) and the data obtained after processing are compared (25) to the identification data of the subscriber and the subscriber card in the possession of the computer service (18) of the telecommunication operator.
Patent JP-3223300-B2 (JP)
IPC: A61M13/00
Filed: 1993-03-13
Granted: 2001-10-29
Abstract: A separator for attachment to devices for administration of powders into the lungs, which separator separates particles to be inhaled into the lungs from other particles in the powders.
Patent JP-3255418-B2 (JP)
IPC: H03L7/081
Filed: 1994-03-24
Granted: 2002-02-12
Abstract: An unlimited number of steps or increments of given size are obtained in a delay line for phase alignment of, for instance, the signal from a crystal oscillator by momentarily switching between two parallel delay lines. One delay line operates as an active or enabled delay line while the other line is disabled or inactive. It is ensured at the same time that the inactive delay line produces a signal which has the same relative phase as the active delay line, this absolute phase differing by Nx2 pi , where N is a positive or a negative integer other than zero. The active delay line operate constantly within its regulation range and the phase of the local oscillator can be kept continuously locked to the phase of the reference signal.
Patent JP-4001622-B2 (JP)
IPC: A61K31/00
Filed: 1995-03-23
Granted: 2007-10-31
Abstract: PCT No. PCT/EP95/01099 Sec. 371 Date Sep. 30, 1996 Sec. 102(e) Date Sep. 30, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26716 PCT Pub. Date Oct. 12, 1995A method of inhibiting endothelin receptors by administering to a patient a compound of the formula I    <IMAGE>  I